ALMS (Alumis Inc. Common Stock) Stock Analysis - Analyst Ratings

Alumis Inc. Common Stock (ALMS) is a publicly traded Healthcare sector company. As of May 21, 2026, ALMS trades at $22.66 with a market cap of $2.70B and a P/E ratio of -12.17. ALMS moved +2.37% today. Year to date, ALMS is +165.22%; over the trailing twelve months it is +351.64%. Its 52-week range spans $2.76 to $30.60. Analyst consensus is strong buy with an average price target of $40.44. Rallies surfaces ALMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ALMS?

9 analysts cover ALMS: 0 strong buy, 8 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $40.44.

ALMS Key Metrics

Key financial metrics for ALMS
MetricValue
Price$22.66
Market Cap$2.70B
P/E Ratio-12.17
EPS$-1.78
Dividend Yield0.00%
52-Week High$30.60
52-Week Low$2.76
Volume112
Avg Volume0
Revenue (TTM)$8.40M
Net Income$-237.41M
Gross Margin0.00%

ALMS Analyst Consensus

9 analysts cover ALMS: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.44.

Latest ALMS News

Recent ALMS Insider Trades

  • AKKARAJU SRINIVAS bought 588.24K (~$10.00M) on Jan 9, 2026.
  • Foresite Labs, LLC bought 117.65K (~$2.00M) on Jan 8, 2026.
  • Foresite Labs, LLC bought 294.12K (~$5.00M) on Jan 8, 2026.

Common questions about ALMS

What do analysts rate ALMS?
9 analysts cover ALMS: 0 strong buy, 8 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $40.44.
Does Rallies show ALMS price targets?
Yes. Rallies tracks ALMS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ALMS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ALMS. It does not provide personalized investment advice.
ALMS

ALMS